Carbapenem-resistant Enterobacteriaceae Infection

• CLINICAL_TRIALS research · 2026-03-19
  Clinical Trial Update: FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae [Phase 1, Phase 2]

  A Phase 1/2 clinical trial is evaluating fecal microbiota transplantation to decolonize patients carrying carbapenem-resistant Enterobacteri…

• CLINICAL_TRIALS research · 2026-03-16
  Clinical Trial Update: Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children

  A pediatric study sponsored by Children's Hospital of Fudan University is investigating risk factors for colonization or infection with carb…

• CLINICAL_TRIALS research · 2025-09-08
  Clinical Trial Update: Microbiological and Clinical Characteristics of Severe Infections Caused by Carbapenem-Resistant Enterobacterales

  This ClinicalTrials.gov entry outlines a study investigating microbiological and clinical characteristics of severe infections caused by car…

• CLINICAL_TRIALS research · 2025-07-25
  Clinical Trial Update: Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia.

  A clinical trial is evaluating different methods of inhaled aerosolized polymyxin B to treat pneumonia caused by carbapenem-resistant gram-n…

• CLINICAL_TRIALS research · 2025-06-24
  Clinical Trial Update: Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated Animals [NA]

  This clinical trial aims to test interventions to reduce carbapenem-resistant Enterobacteriaceae (CRE) colonization and transmission across …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-06-19
  Clinical Trial Update: Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract [NA]

  A clinical trial evaluating the efficacy and safety of fecal microbiota transplantation to decolonize multi-drug resistant organisms, specif…

• CLINICAL_TRIALS research · 2025-05-18
  Clinical Trial Update: Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection [NA]

  Clinical trial evaluating the efficacy and safety of colistimethate sodium for injection in treating Carbapenem-Resistant Enterobacteriaceae…

• CLINICAL_TRIALS research · 2025-03-12
  Clinical Trial Update: FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae [Phase 1, Phase 2]

  This update covers a Phase 1/2 clinical trial evaluating fecal microbiota transplantation to eradicate intestinal colonization by carbapenem…

• CLINICAL_TRIALS research · 2024-04-30
  Clinical Trial Update: Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units

  A clinical trial in Tunisian intensive care units is studying epidemiological features of emergent highly resistant bacteria, with recruitme…

• CLINICAL_TRIALS research · 2020-01-27
  Clinical Trial Update: Fecal Microbiota Transplantation for Eradication of CRE [Phase 1, Phase 2]

  Clinical trial update on fecal microbiota transplantation to eradicate carbapenem-resistant Enterobacteriaceae (CRE) in Phase 1/2 completed.

• CLINICAL_TRIALS research · 2016-06-20
  Clinical Trial Update: Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region

  A clinical trial update from CHU de Reims describes the prevalence of carbapenem-nonsusceptible Enterobacteriaceae in the Eastern Inter-Regi…